{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:30:56Z","timestamp":1793406656239,"version":"4.5.0"},"reference-count":69,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epstein-Barr virus (EBV), a common childhood infection, is associated with Burkitt lymphoma, Hodgkin lymphoma, and nasopharyngeal cancer. We estimated the proportion and number of cancers attributable to EBV among individuals aged \u226419\u2009years in Europe and North America in 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Embase and MEDLINE were searched from inception to August 25, 2025. Cancer incidence was derived from GLOBOCAN. We included studies where cancer tissue from \u22658 individuals aged \u226419\u2009years residing in Europe or North America was tested for EBV. Pooled EBV prevalence and 95% confidence intervals (CIs) were estimated using random-effects models. To obtain EBV-attributable cases, pooled prevalence was multiplied by cancer incidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After screening 17\u2009388 titles\/abstracts and 1084 full-texts, 53 studies met the inclusion criteria for Burkitt lymphoma (9 studies, 433 cases), Hodgkin lymphoma (40 studies, 3197 cases), and nasopharyngeal cancer (4 studies, 62 cases). The pooled prevalence of EBV was 19.7% (CI = 10.2 to 34.7%, I2 = 69.5%) in Burkitt lymphoma, 33.4% (CI = 27.4 to 40.0%, I2 = 75.6%) in Hodgkin lymphoma, and 96.8% (CI = 88.0 to 99.2%, I2 = 0.0%) in nasopharyngeal cancer. An estimated 1166 (2.8%) of 41\u2009366 cancers diagnosed in 2022 were attributable to EBV. These cases comprised 899 Hodgkin lymphomas, 140 Burkitt lymphomas, and 127 nasopharyngeal cancers. The burden was higher among males (3.2% vs 2.3% for females) and those aged 10 to 14\u2009years (5.0% vs 1.7% for 0 to 9-year-olds and 3.1% for 15 to 19-year-olds).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In 2022, 2.8% of childhood cancers diagnosed in Europe and North America were attributable to EBV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djag344","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:45:59Z","timestamp":1790855159000},"source":"Crossref","is-referenced-by-count":0,"title":["Epstein-Barr virus-attributable cancers among children and adolescents in Europe and North America: a meta-analysis"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4443-3006","authenticated-orcid":false,"given":"Karena D","family":"Volesky-Avellaneda","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology, McGill University , Montreal, Quebec,","place":["Canada"]},{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University , Montreal, Quebec,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Tsyruk-Romano","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology, McGill University , Montreal, Quebec,","place":["Canada"]},{"name":"Department of Medicine, Western University , London, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Hildesheim","sequence":"additional","affiliation":[{"name":"Agencia Costarricense de Investigaciones Biom\u00e9dicas , San Jos\u00e9,","place":["Costa Rica"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D","family":"Walter","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University , Hamilton, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5190-0370","authenticated-orcid":false,"given":"Mariam","family":"El-Zein","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology, McGill University , Montreal, Quebec,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M","family":"Friedenreich","sequence":"additional","affiliation":[{"name":"Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta , Calgary, Alberta,","place":["Canada"]},{"name":"Departments of Oncology and Community Health Sciences, University of Calgary , Calgary, Alberta,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren R","family":"Brenner","sequence":"additional","affiliation":[{"name":"Departments of Oncology and Community Health Sciences, University of Calgary , Calgary, Alberta,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4409-8084","authenticated-orcid":false,"given":"Eduardo L","family":"Franco","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology, McGill University , Montreal, Quebec,","place":["Canada"]},{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University , Montreal, Quebec,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2026103019465965300_djag344-B1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S2352-4642(18)30095-6","article-title":"Causes of death among children aged 5-14 years in the WHO European Region: a systematic analysis for the Global Burden of Disease Study 2016","volume":"2","author":"Kyu","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"2026103019465965300_djag344-B2","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1056\/NEJMsr1804754","article-title":"The major causes of death in children and adolescents in the United States","volume":"379","author":"Cunningham","year":"2018","journal-title":"N Engl J Med"},{"key":"2026103019465965300_djag344-B3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026103019465965300_djag344-B4","author":"American Cancer Society"},{"key":"2026103019465965300_djag344-B5","author":"Cancer Research UK"},{"key":"2026103019465965300_djag344-B6","author":"International Agency for Research on Cancer"},{"key":"2026103019465965300_djag344-B7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/s0140-6736(64)91524-7","article-title":"V","volume":"283","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"2026103019465965300_djag344-B8","author":"International Agency for Research on Cancer","year":"2012"},{"key":"2026103019465965300_djag344-B9","doi-asserted-by":"publisher","author":"National Toxicology Program","year":"2016","DOI":"10.22427\/ROC-MGRAPH-07"},{"key":"2026103019465965300_djag344-B10","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt\u2019s lymphoma","volume":"379","author":"Molyneux","year":"2012","journal-title":"Lancet"},{"key":"2026103019465965300_djag344-B11","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1158\/1055-9965.EPI-08-0461","article-title":"Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications","volume":"17","author":"Bray","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026103019465965300_djag344-B12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-019-0799-1","article-title":"Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study","volume":"12","author":"Zhou","year":"2019","journal-title":"J Hematol Oncol"},{"key":"2026103019465965300_djag344-B13","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/S1470-2045(26)00307-4","article-title":"Global burden of cancer attributable to infections in 2024: a worldwide incidence analysis","volume":"27","author":"Rumgay","year":"2026","journal-title":"Lancet Oncol"},{"key":"2026103019465965300_djag344-B14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancer attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de Martel","year":"2012","journal-title":"Lancet Oncol"},{"key":"2026103019465965300_djag344-B15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"2026103019465965300_djag344-B16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1750-9378-9-38","article-title":"Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010","volume":"9","author":"Khan","year":"2014","journal-title":"Infect Agent Cancer"},{"key":"2026103019465965300_djag344-B17","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1038\/bjc.2011.484","article-title":"11. Cancers attributable to infection in the UK in 2010","volume":"105 Suppl 2","author":"Parkin","year":"2011","journal-title":"Br J Cancer"},{"key":"2026103019465965300_djag344-B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"2026103019465965300_djag344-B19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/1093526618807110","article-title":"Primary nonanaplastic peripheral natural killer\/T-cell lymphoma in pediatric patients\u2014an unusual distribution pattern of subtypes","volume":"22","author":"Wilberger","year":"2019","journal-title":"Pediatr Dev Pathol"},{"key":"2026103019465965300_djag344-B20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1346-8138.12322","article-title":"Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disorders","volume":"41","author":"Park","year":"2014","journal-title":"J Dermatol"},{"key":"2026103019465965300_djag344-B21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2353\/jmoldx.2008.080023","article-title":"Laboratory assays for Epstein-Barr virus-related disease","volume":"10","author":"Gulley","year":"2008","journal-title":"J Mol Diagn"},{"key":"2026103019465965300_djag344-B22","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/jcp.2006.044586","article-title":"Epstein Barr virus-associated tumours: an update for the attention of the working pathologist","volume":"60","author":"Delecluse","year":"2007","journal-title":"J Clin Pathol"},{"key":"2026103019465965300_djag344-B23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2026103019465965300_djag344-B24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.arcmed.2014.06.001","article-title":"Prevalence and prognostic significance of Epstein-Barr virus infection in classical Hodgkin\u2019s lymphoma: a meta-analysis","volume":"45","author":"Lee","year":"2014","journal-title":"Arch Med Res"},{"key":"2026103019465965300_djag344-B25","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"2026103019465965300_djag344-B26","volume-title":"Version EndNote X9","author":"EndNote","year":"2013"},{"key":"2026103019465965300_djag344-B27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"2026103019465965300_djag344-B28","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"key":"2026103019465965300_djag344-B29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13690-023-01215-y","article-title":"Methods for meta-analysis and meta-regression of binomial data: concepts and tutorial with Stata command metapreg","volume":"82","author":"Nyaga","year":"2024","journal-title":"Arch Public Health"},{"key":"2026103019465965300_djag344-B30","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1634\/theoncologist.2008-0036","article-title":"EBV-associated lymphoproliferative disorders: classification and treatment","volume":"13","author":"Carbone","year":"2008","journal-title":"Oncologist"},{"key":"2026103019465965300_djag344-B31","first-page":"1889","article-title":"European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes","volume":"96","author":"Anagnostopoulos","year":"2000","journal-title":"Blood"},{"key":"2026103019465965300_djag344-B32","author":"Steliarova-Foucher","year":"2017"},{"key":"2026103019465965300_djag344-B33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2559.1993.tb00480.x","article-title":"High incidence of Epstein-Barr virus detection in Hodgkin\u2019s disease and absence of detection in anaplastic large-cell lymphoma in children","volume":"23","author":"Brousset","year":"1993","journal-title":"Histopathology"},{"key":"2026103019465965300_djag344-B34","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.3324\/haematol.2021.280342","article-title":"Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance","volume":"107","author":"Fisher","year":"2022","journal-title":"Haematologica"},{"key":"2026103019465965300_djag344-B35","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/s0344-0338(11)80897-6","article-title":"Frequent detection of Epstein-Barr virus (EBV), EBER transcripts and latent membrane protein-1 (LMP-1) in tumor cells in Hodgkin\u2019s disease arising in childhood","volume":"190","author":"Kanavaros","year":"1994","journal-title":"Pathol Res Pract"},{"key":"2026103019465965300_djag344-B36","first-page":"297","volume-title":"Genome and Proteome in Oncology","author":"Karajannis","year":"2005"},{"key":"2026103019465965300_djag344-B37","first-page":"169","article-title":"Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin\u2019s lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules","volume":"45","author":"Kasprzak","year":"2007","journal-title":"Folia Histochem Cytobiol"},{"key":"2026103019465965300_djag344-B38","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1080\/00016489.2021.1918764","article-title":"Clinicopathologic characteristics of Burkitt lymphoma of the head and neck in a non-endemic region\u2014a Danish nationwide study","volume":"141","author":"Dupont Harwood","year":"2021","journal-title":"Acta Otolaryngol"},{"key":"2026103019465965300_djag344-B39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/gcc.20009","article-title":"Interphase fluorescence in situ hybridization for detection of 8q24\/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regions","volume":"40","author":"Haralambieva","year":"2004","journal-title":"Genes Chromosomes Cancer."},{"key":"2026103019465965300_djag344-B40","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1182\/blood-2003-08-2986","article-title":"Epstein-Barr virus infection in Western European pediatric non-Hodgkin lymphomas","volume":"102","author":"Karajannis","year":"2003","journal-title":"Blood"},{"key":"2026103019465965300_djag344-B41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/apm.12078","article-title":"Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009","volume":"122","author":"Mbulaiteye","year":"2013","journal-title":"APMIS"},{"key":"2026103019465965300_djag344-B42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-9378-9-34","article-title":"The role of EBV in the pathogenesis of Burkitt\u2019s Lymphoma: an Italian hospital based survey","volume":"9","author":"Pannone","year":"2014","journal-title":"Infect Agent Cancer"},{"key":"2026103019465965300_djag344-B43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/bjh.17874","article-title":"Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features","volume":"196","author":"Richter","year":"2022","journal-title":"Br J Haematol"},{"key":"2026103019465965300_djag344-B44","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1309\/77V7U4E03V69QHRR","article-title":"TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphoma","volume":"124","author":"Teitell","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"2026103019465965300_djag344-B45","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/(SICI)1097-0142(19970901)80:5&lt;951::AID-CNCR18&gt;3.0.CO;2-V","article-title":"Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91","volume":"80","author":"Mertens","year":"1997","journal-title":"Gesellschaft Fur Padiatrische Onkologie Und Hamatologie. Cancer"},{"key":"2026103019465965300_djag344-B46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/08880010490457060","article-title":"Nasopharyngeal carcinoma in childhood and adolescence: a single institution\u2019s experience with treatment modalities during the last 15 years","volume":"21","author":"Polychronopoulou","year":"2004","journal-title":"Pediatr Hematol Oncol"},{"key":"2026103019465965300_djag344-B47","doi-asserted-by":"publisher","first-page":"850","DOI":"10.2340\/1651-226X.2024.40499","article-title":"Epidemiology and treatment outcome of nasopharyngeal carcinoma in a low-incidence population\u2014a DAHANCA analysis in Denmark 2000-2018","volume":"63","author":"Schiess","year":"2024","journal-title":"Acta Oncol"},{"key":"2026103019465965300_djag344-B48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00432-023-05547-8","article-title":"Nasopharyngeal carcinoma: nationwide trends in subtype-specific incidence and survival over 3 decades in a non-endemic area","volume":"150","author":"van Velsen","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"2026103019465965300_djag344-B49","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.jpedsurg.2005.06.021","article-title":"Inflammatory myofibroblastic tumor in children: clinical review with anaplastic lymphoma kinase, Epstein-Barr virus, and human herpesvirus 8 detection analysis","volume":"40","author":"Mergan","year":"2005","journal-title":"J Pediatr Surg"},{"key":"2026103019465965300_djag344-B50","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/1097-0142(20000715)89:2&lt;463::aid-cncr35&gt;3.0.co;2-r","article-title":"Epstein-Barr virus infection in salivary gland tumors in children and young adults","volume":"89","author":"Venkateswaran","year":"2000","journal-title":"Cancer"},{"key":"2026103019465965300_djag344-B51","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature25480","article-title":"The landscape of genomic alterations across childhood cancers","volume":"555","author":"Gr\u00f6bner","year":"2018","journal-title":"Nature"},{"key":"2026103019465965300_djag344-B52","doi-asserted-by":"publisher","first-page":"-2346","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline mutations in predisposition genes in pediatric cancer","volume":"37","author":"Zhang","year":"2015","journal-title":"N Engl J Med"},{"key":"2026103019465965300_djag344-B53","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"2026103019465965300_djag344-B54","author":"International Agency for Research on Cancer","year":"2008"},{"key":"2026103019465965300_djag344-B55","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ctrv.2010.02.011","article-title":"The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas","volume":"36","author":"Cader","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"2026103019465965300_djag344-B56","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10060163","article-title":"Epstein Barr virus-associated Hodgkin lymphoma","volume":"10","author":"Carbone","year":"2018","journal-title":"Cancers (Basel)"},{"key":"2026103019465965300_djag344-B57","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s00066-019-01461-6","article-title":"Adapted strategy to tumor response in childhood nasopharyngeal carcinoma: the French experience","volume":"195","author":"Jouin","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"2026103019465965300_djag344-B58","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/infdis\/jit321","article-title":"Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition","volume":"208","author":"Balfour","year":"2013","journal-title":"J Infect Dis"},{"key":"2026103019465965300_djag344-B59","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1186\/s12879-019-4578-y","article-title":"Predictors of Epstein-Barr virus serostatus in young people in England","volume":"19","author":"Winter","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2026103019465965300_djag344-B60","year":"2012"},{"key":"2026103019465965300_djag344-B61","volume":"100 F.","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2012","journal-title":"A Review of Human Carcinogens: Chemical Agents and Related Occupations"},{"key":"2026103019465965300_djag344-B62","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrmicro3268","article-title":"Co-factors in Epstein-Barr virus-related malignancy","volume":"12","author":"Rickinson AB.","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"2026103019465965300_djag344-B63","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-pathmechdis-012418-013023","article-title":"Epstein-Barr Virus and Cancer","volume":"14","author":"Farrell","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"2026103019465965300_djag344-B64","volume-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","author":"Ambinder","year":"2007"},{"key":"2026103019465965300_djag344-B65","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancer attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Glob Health"},{"key":"2026103019465965300_djag344-B66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s1040-8428(00)00046-9","article-title":"Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications","volume":"34","author":"Hsu","year":"2000","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026103019465965300_djag344-B67","doi-asserted-by":"publisher","DOI":"10.3390\/v17070936","article-title":"Recent progress in the vaccine development against Epstein-Barr virus","volume":"17","author":"Dai","year":"2025","journal-title":"Viruses"},{"key":"2026103019465965300_djag344-B68","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/pas.0000000000000107","article-title":"EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults","volume":"38","author":"Huppmann","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"2026103019465965300_djag344-B69","first-page":"2114","article-title":"Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin\u2019s lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome","volume":"9","author":"Herling","year":"2003","journal-title":"Clin Cancer Res"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag344\/71559984\/djag344.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag344\/71559984\/djag344.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:47:02Z","timestamp":1793404022000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article\/doi\/10.1093\/jnci\/djag344\/8859110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":69,"URL":"https:\/\/doi.org\/10.1093\/jnci\/djag344","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"djag344"}}